U.S., Oct. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07870369) titled 'Cardiovascular Risk in Patients With Primary Hyperparathyroidism' on Oct. 06.
Brief Summary: Patients with primary hyperparathyroidism versus healthy controls assessed for their cardiovascular risk and overt CVD
Study Start Date: Jan. 01, 2023
Study Type: OBSERVATIONAL
Condition:
Heart Failure
Atrial Fibrillation (AF)
Arrhythmia
Coronary Artery Disease
Hypertension (HTN)
Recruitment Status: COMPLETED
Sponsor: Medical University of Sofia
Information provided by (Responsible Party): Stefan Naydenov Naydenov, Medical University of Sofia
Published by HT Digital Content Services with permission from Health Daily Digest....